Prevention of Type I Diabetes in Nonobese Diabetic Mice by Late Intervention with Nonhypercalcemic Analogs of 1,25-Dihydroxyvitamin D3 in Combination with a Short Induction Course of Cyclosporin A
The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In nonobese diabetic (NOD) mice, type I diabetes can be prevented without generalized immunosuppression by nonhypercalcemic analogs of vitamin D3 when treatment is started early, i.e. before the autoimmune attack, reflected by insulitis, occurs. The aim of this study was to investigate whether these substances can arrest progression to clinically overt diabetes when administered in a more advanced disease stage, namely when the autoimmune attack is ongoing, reflecting the situation in prediabetic subjects in whom immune intervention is being considered. We, therefore, evaluated the protective potential of MC1288 (20-epi-1,25-dihydroxyvitamin D3) a nonhypercalcemic analog of 1,25-dihydroxyvitamin D3, both alone and in combination with a short induction course of cyclosporin A, in NOD mice that already have insulitis, as demonstrated in pancreatic biopsies performed 15 days before the start oftherapy. Subsequently, mice were randomized into a control group, receiving the treatment vehicle (n = 26), and three treatment groups, receiving, respectively, 7.5 mg/kg x day cyclosporin A (CyA) from days 85-105 (n = 19), 0.1 microg/kg x 2 days MC1288 from days 85-200 (n = 20), or the combination of these two regimens (n = 20). At the time of the pancreatic biopsy (day 70), insulitis was evenly distributed in all groups, and 27.7% of the islets scored showed signs of destructive insulitis. Diabetes outcome by 200 days was 74% (14 of 19) in the CyA-treated group, comparable to the diabetes incidence in control mice (65%; 17 of 26; P = NS). Treatment with MC1288 alone could not reduce disease incidence (70%; 14 of 20), but the combination therapy reduced diabetes incidence to 35% (7 of 20; P < 0.05 vs. untreated; P < 0.01 vs. CyA group; P < 0.025 vs. MC1288). All treatments were well tolerated, without major side-effects on calcium or bone metabolism and without signs of generalized immunosuppression. Cotransfer experiments could not reveal the induction of suppressor cells. Reverse transcription-PCR on pancreatic tissue revealed significantly lower levels of interferon-gamma and higher levels of interleukin-4 in the combination group. In conclusion, nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 administered to NOD mice when the autoimmune disease is already active can prevent clinical diabetes when this therapy is combined with a short induction course of an immunosuppressant such as CyA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
Self-citationAn Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene Expression
Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., & Mathieu, C. (2001) · Methods · doi:10.1006/meth.2001.1261 · Cited by 1,411
Self-citationImmunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
Etten, E. V., & Mathieu, C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.002 · Cited by 880
Self-citationAnimal models of diabetes mellitus
Rees, D. A., & Alcolado, J. C. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01499.x · Cited by 731
QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCR
Overbergh, L., Valckx, D., Waer, M., & Mathieu, C. (1999) · Cytokine · doi:10.1006/cyto.1998.0426 · Cited by 557
Self-citationGregori, S., Giarratana, N., Smiroldo, S., Uskokovic, M., & Adorini, L. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1367 · Cited by 483
Holick, M. F. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200202000-00011 · Cited by 477
The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
Mathieu, C., & Adorini, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02294-3 · Cited by 465
Self-citationNew insights into the mechanisms of vitamin D action
Christakos, S., Dhawan, P., Liu, Y., Peng, X., & Porta, A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10423 · Cited by 324
Antico, A., Tampoia, M., Tozzoli, R., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.007 · Cited by 297
Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages
Overbergh, L., Decallonne, B., Valckx, D., Verstuyf, A., Depovere, J., Laureys, J., Rutgeerts, O., Saint-Arnaud, R., Bouillon, R., & Mathieu, C. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01204.x · Cited by 275
Self-citationInfluence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes
Infante, M., Ricordi, C., Sanchez, J., Clare-Salzler, M. J., Padilla, N., Fuenmayor, V., Chavez, C., Alvarez, A., Baidal, D., Alejandro, R., et al. (2019) · Nutrients · doi:10.3390/nu11092185 · Cited by 272
Takiishi, T., Gysemans, C., Bouillon, R., & Mathieu, C. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.02.013 · Cited by 270
Self-citationMechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease
Muscogiuri, G., Mitri, J., Mathieu, C., Badenhoop, K., Tamer, G., Orio, F., Mezza, T., Vieth, R., Colao, A., & Pittas, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0158 · Cited by 157
Self-citationAltieri, B., Grant, W. B., Della Casa, S., Orio, F., Pontecorvi, A., Colao, A., Sarno, G., & Muscogiuri, G. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1136922 · Cited by 113
Metadata
- Authors
- Casteels, K. M., Mathieu, C., Waer, M., Valckx, D., Overbergh, L., Laureys, J. M., & Bouillon, R.
- Venue
- Endocrinology
- Publisher
- Oxford University Press
- Published
- 1998-01-01
- Volume
- 139
- Issue
- 1
- Pages
- 95-102
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2157690864
- Cited by
- 122
- References
- 1
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.